Merck Serono and Illumina Enter Strategic Collaboration for Diagnostics in Oncology
Merck Serono and Illumina, Inc., announced a collaboration to expand the development of a universal next-generation sequencing-based oncology diagnostic for clinical trials of targeted cancer therapies.
Under the terms of the agreement, Merck Serono and Illlumina will work together to develop assays that detect and simultaneously measure multiple genetic variants in a single tumor sample in a clinical trial setting. Illumina’s successful regulatory track record was an important consideration in the collaboration, as next-generation sequencing platforms cleared by a regulatory agency could accelerate the development of an assay and facilitate the registration of a companion diagnostic.
“Our collaboration with Illumina around next-generation sequencing will enable us to perform genome studies at a pace unheard of a few years ago, and could lead to the development of several diagnostics,” said Susan Herbert, Head of Global Business Development at Merck Serono. “This collaboration will strengthen the position of Merck Serono as a global leader in precision medicine in oncology.”
The collaboration will include development of the diagnostic, worldwide regulatory approvals, and global commercialization.
Most read news
Topics
Organizations
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
See the theme worlds for related content
Last viewed contents
MolecularHealth Partners with GATC Biotech for Genetic Sequencing Technology and Expertise
Ångström-Resolution Fluorescence Microscopy - This innovation is poised to usher in a paradigm shift in our approach to study biological systems with thus far unprecedented detail
Study gives clues to increasing X-rays' power - 3-D, real-time X-ray images may be closer to reality
Roche Diagnostics Licenses the Technology used for the LightCycler System to BIOTECON
Track and trace members of the plant microbiome with DNA barcodes
Innovative microscopy technique reveals secrets of lipid synthesis inside cells - Two-color infrared photothermal microscopy (2C-IPM) opens new avenues for long-term study of lipid metabolism in living cells
Millipore Names New VP of Life Science Business Unit - John Sweeney to focus on technology development and partnerships
The deadly toxin acrolein has a useful biological role
Making a better nitrate test kit
Novel Laser Technology for Microchip-Size Chemical Sensors
Microorganisms build the best fuel efficient hydrogen cells